Suggestions
Gigi Gronvall
Professional Background
Gigi Kwik Gronvall is a distinguished expert in the fields of public health and biomedical research, with a particularly focused expertise in biodefense and infectious disease preparedness. As a Senior Scholar at the Johns Hopkins Center for Health Security, she has played a pivotal role in advancing our understanding of public health threats and the policies required to address them. Her extensive research covers a broad spectrum, including vaccine development, outbreak response, and health security strategies aimed at biological threats. Gigi's work seamlessly integrates scientific insights with pragmatic policy recommendations, making meaningful contributions to national and global health security. Throughout her career, she has been involved in numerous high-profile initiatives and government advisory roles, ensuring her voice is integral to the discourse on public health safety.
Education and Achievements
Gigi Kwik Gronvall holds an impressive academic background marked by rigorous education and specialized training. She earned her Doctorate in Immunology from the University of Chicago, a prestigious institution renowned for its research excellence in the health sciences. This foundational education laid the groundwork for her formidable understanding of immunological processes and their applications in disease prevention and control. Furthermore, her Doctorate has equipped her with the analytical skills necessary to address complex public health challenges with scientific rigor.
In addition to her formal education, Dr. Gronvall has published extensively in peer-reviewed journals, contributing significant research findings that enhance our understanding of epidemiological trends and health interventions. Her publications cover various topics, from the effectiveness of biodefense strategies to the socio-political factors influencing vaccine uptake. These works not only reflect her expertise but also serve as vital resources for researchers, policymakers, and public health officials.
Notable Contributions and Achievements
Gigi's career is dotted with various notable achievements that speak volumes of her commitment and impact in the field of health security. She has served as an advisor to several governmental agencies, including the Centers for Disease Control and Prevention (CDC) and the Department of Health and Human Services (HHS), where her advice has directly influenced national policies on health security and emergency responses during public health crises.
Additionally, Dr. Gronvall is recognized for her role as a co-author in key reports that shape the strategic approaches to preparedness against infectious diseases and bioterrorism. Her comprehensive analyses provide indispensable insights into risk assessment and management strategies, thereby reinforcing the resilience of public health infrastructures.
Through her ongoing work, Gigi continues to engage with various stakeholders, including public and private sectors, to foster collaborative efforts aimed at strengthening health security globally. Her advocacy for better preparedness systems illustrates her deep-seated belief in the power of interdisciplinary cooperation in tackling global health challenges.
Current Initiatives
Currently, Gigi Kwik Gronvall is engaged in projects that focus on improving the U.S. response to infectious diseases while also promoting global health security initiatives. Her contemporary work emphasizes the importance of vaccine research, development, and strategic deployment, particularly in light of emergent health threats such as pandemics and antibiotic resistance. Through outreach programs and educational initiatives, she aims to equip the next generation of public health professionals with the knowledge and skills necessary to adapt to an ever-changing world.
As a thought leader, Gigi is also frequently invited to share her insights at national and international conferences, providing platforms for dialogue about best practices in health security. Her contributions serve not only to educate but also to inspire actionable change across various health sectors. Whether through speaking engagements or collaborative workshops, she aims to bridge gaps in knowledge and foster a culture of preparedness against biological threats.
Conclusion
Gigi Kwik Gronvall's career is marked by a notable commitment to public health, serving as a hallmark of expertise in biodefense and infectious disease management. Her educational accomplishments, alongside her substantial contributions to health security policy and research, underscore her essential role as a leader in this vital field. As challenges in public health continue to evolve, professionals like Gigi are crucial in navigating these complexities and promoting a safer, healthier future for all.
Highlights
Excited to dive into a new NASEM study on AI and biosecurity-- directed by the President in Executive Order 14110-- which aims to assess how AI may increase biosecurity/national security risks and how to mitigate those risks. This study will build on the 2018 Biodefense in an Age of Synthetic Biology report, and I'm personally excited to work with Michael Imperiale (who will co-chair) and Patrick Boyle again, along with other amazing committee members I know like Alexander Titus and Jens H. Kuhn and others I am looking forward to meeting.
Sharing my new article in Applied Biosafety with Steph Batalis, Caroline Schuerger and Matthew E. Walsh on "Safeguarding Mail-Order DNA Synthesis in the Age of Artificial Intelligence." Matt, who is focusing on the impact of AI on biosecurity for his PhD, is the corresponding author for this piece. https://lnkd.in/etRRTGPP
In this article, we examine the impact of AI tools on the biosecurity landscape surrounding mail-order DNA synthesis. For example, chatbots may lower barriers to accessing information by nefarious users, but they are unlikely to meaningfully expand the number of individuals who are actually able to misuse biology. Why is that? Because access and knowledge of how to access synthetic DNA is an early step in a loooong pathway to misuse.
Unlike chatbots, Biological design tools (BDTs) may provide new abilities to nefarious users-- eg helping users evade current DNA synthesis screening protocols by designing sequences not included on the list of known pathogens checked before synthesis. However, there are lots of caveats, including that mail-order DNA synthesis is absolutely not the only path for access to genetic material, not all companies screen their gene synthesis orders, and these are still early days for BDTs and what can be done for both positive/negative ends.
Among our recommendations: we should expand screening of gene synthesis orders, internationally. US federal research dollars should not be used to purchase from companies which do not screen (Congress should codify what was in the recent AI EO). We recommend the USG invest in "violet teaming" (for more info on that please see the work of Alexander Titus) which identifies threats arising from a technology, and then using the same technology to build tools to address the threat without creating a harmful product (as you might in red teaming methodologies).
Finally, the USG should provide funding and resources to develop and implement biosecurity education and training for researchers, because having security in mind during the development and refinement of new tools will help limit misuse.
